Speaker Bio
I am the Director of Digital Precision Oncology at AstraZeneca's Global Hub in Barcelona. I leverage advanced modeling and machine learning on multimodal data to uncover treatment response insights, driving progress in precision medicine and transforming cancer care.
I am passionate about using quantitative approaches to decode biology—translating complex phenomena into actionable predictions and simulations that can directly be applied to cancer care and impact patients. This belief has guided my journey across multiple scales of biological discovery.
My path began at the molecular level during my Ph.D., where I studied quantum and molecular interactions shaping protein structures and dynamics. In my postdoc, I dissected signaling pathways in cell migration and cancer at the cellular level via single-molecule microscopy. This journey—from molecules to patients—continued through my consulting work and my time at AstraZeneca France where I delivered innovative RWE oncology projects and acted as a Market access/HTA/RWE/HEOR consultant and expert 30+ European/International pharma advisory boards.